Order Article Reprints

Signorelli C, Chilelli MG, Giannarelli D, Basso M, Calegari MA, Anghelone A, Lucchetti J, Minelli A, Angotti L, Zurlo IV, et al. Retrospective Correlation between First Drug Treatment Duration and Survival Outcomes in Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: A Real-World Subgroup Analysis. Cancers. 2023; 15(24):5758. https://doi.org/10.3390/cancers15245758

Signorelli, Carlo, Mario Giovanni Chilelli, Diana Giannarelli, Michele Basso, Maria Alessandra Calegari, Annunziato Anghelone, Jessica Lucchetti, Alessandro Minelli, Lorenzo Angotti, Ina Valeria Zurlo, and et al. 2023. "Retrospective Correlation between First Drug Treatment Duration and Survival Outcomes in Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: A Real-World Subgroup Analysis" Cancers 15, no. 24: 5758. https://doi.org/10.3390/cancers15245758

Signorelli, C., Chilelli, M. G., Giannarelli, D., Basso, M., Calegari, M. A., Anghelone, A., Lucchetti, J., Minelli, A., Angotti, L., Zurlo, I. V., Schirripa, M., Morelli, C., Dell’Aquila, E., Cosimati, A., Gemma, D., Ribelli, M., Emiliani, A., Corsi, D. C., Arrivi, G., ... Ruggeri, E. M. (2023). Retrospective Correlation between First Drug Treatment Duration and Survival Outcomes in Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: A Real-World Subgroup Analysis. Cancers, 15(24), 5758. https://doi.org/10.3390/cancers15245758